These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 18480474)
1. Screening for antiviral inhibitors of the HIV integrase-LEDGF/p75 interaction using the AlphaScreen luminescent proximity assay. Hou Y; McGuinness DE; Prongay AJ; Feld B; Ingravallo P; Ogert RA; Lunn CA; Howe JA J Biomol Screen; 2008 Jun; 13(5):406-14. PubMed ID: 18480474 [TBL] [Abstract][Full Text] [Related]
2. Pharmacophore-based discovery of small-molecule inhibitors of protein-protein interactions between HIV-1 integrase and cellular cofactor LEDGF/p75. De Luca L; Barreca ML; Ferro S; Christ F; Iraci N; Gitto R; Monforte AM; Debyser Z; Chimirri A ChemMedChem; 2009 Aug; 4(8):1311-6. PubMed ID: 19565598 [TBL] [Abstract][Full Text] [Related]
3. Differential interaction of HIV-1 integrase and JPO2 with the C terminus of LEDGF/p75. Bartholomeeusen K; De Rijck J; Busschots K; Desender L; Gijsbers R; Emiliani S; Benarous R; Debyser Z; Christ F J Mol Biol; 2007 Sep; 372(2):407-21. PubMed ID: 17669426 [TBL] [Abstract][Full Text] [Related]
4. Inhibitory profile of a LEDGF/p75 peptide against HIV-1 integrase: insight into integrase-DNA complex formation and catalysis. Al-Mawsawi LQ; Christ F; Dayam R; Debyser Z; Neamati N FEBS Lett; 2008 Apr; 582(10):1425-30. PubMed ID: 18331842 [TBL] [Abstract][Full Text] [Related]
5. Inhibitors of the interactions between HIV-1 IN and the cofactor LEDGF/p75. De Luca L; Ferro S; Morreale F; De Grazia S; Chimirri A ChemMedChem; 2011 Jul; 6(7):1184-91. PubMed ID: 21506277 [TBL] [Abstract][Full Text] [Related]
6. The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy. Christ F; Debyser Z Virology; 2013 Jan; 435(1):102-9. PubMed ID: 23217620 [TBL] [Abstract][Full Text] [Related]
7. D77, one benzoic acid derivative, functions as a novel anti-HIV-1 inhibitor targeting the interaction between integrase and cellular LEDGF/p75. Du L; Zhao Y; Chen J; Yang L; Zheng Y; Tang Y; Shen X; Jiang H Biochem Biophys Res Commun; 2008 Oct; 375(1):139-44. PubMed ID: 18691555 [TBL] [Abstract][Full Text] [Related]
8. Identification of the LEDGF/p75 binding site in HIV-1 integrase. Busschots K; Voet A; De Maeyer M; Rain JC; Emiliani S; Benarous R; Desender L; Debyser Z; Christ F J Mol Biol; 2007 Feb; 365(5):1480-92. PubMed ID: 17137594 [TBL] [Abstract][Full Text] [Related]
9. Computational studies of the interaction between the HIV-1 integrase tetramer and the cofactor LEDGF/p75: insights from molecular dynamics simulations and the informational spectrum method. Tintori C; Veljkovic N; Veljkovic V; Botta M Proteins; 2010 Dec; 78(16):3396-408. PubMed ID: 20878714 [TBL] [Abstract][Full Text] [Related]
10. On the cell biology of HIV integration from basic research to development of novel antiviral drugs. Debyser Z; Christ F Verh K Acad Geneeskd Belg; 2010; 72(5-6):219-37. PubMed ID: 21409951 [TBL] [Abstract][Full Text] [Related]
11. In vitro DNA tethering of HIV-1 integrase by the transcriptional coactivator LEDGF/p75. McNeely M; Hendrix J; Busschots K; Boons E; Deleersnijder A; Gerard M; Christ F; Debyser Z J Mol Biol; 2011 Jul; 410(5):811-30. PubMed ID: 21763490 [TBL] [Abstract][Full Text] [Related]
12. The evaluation of statins as potential inhibitors of the LEDGF/p75-HIV-1 integrase interaction. Harrison AT; Kriel FH; Papathanasopoulos MA; Mosebi S; Abrahams S; Hewer R Chem Biol Drug Des; 2015 Mar; 85(3):290-5. PubMed ID: 24954548 [TBL] [Abstract][Full Text] [Related]
13. New scaffolds of natural origin as Integrase-LEDGF/p75 interaction inhibitors: virtual screening and activity assays. De Luca L; Morreale F; Christ F; Debyser Z; Ferro S; Gitto R Eur J Med Chem; 2013 Oct; 68():405-11. PubMed ID: 23994868 [TBL] [Abstract][Full Text] [Related]
14. [LEDGF/p75: a novel target for anti-HIV therapy and advances in the study of its related inhibitors]. Chen WM; Liu XY Yao Xue Xue Bao; 2009 Sep; 44(9):953-60. PubMed ID: 20055168 [TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of the chromatin-binding domains of the HIV-1 integrase interactor LEDGF/p75. Llano M; Vanegas M; Hutchins N; Thompson D; Delgado S; Poeschla EM J Mol Biol; 2006 Jul; 360(4):760-73. PubMed ID: 16793062 [TBL] [Abstract][Full Text] [Related]
16. Virus evolution reveals an exclusive role for LEDGF/p75 in chromosomal tethering of HIV. Hombrouck A; De Rijck J; Hendrix J; Vandekerckhove L; Voet A; De Maeyer M; Witvrouw M; Engelborghs Y; Christ F; Gijsbers R; Debyser Z PLoS Pathog; 2007 Mar; 3(3):e47. PubMed ID: 17397262 [TBL] [Abstract][Full Text] [Related]
17. HIV-1 integrase preassembled on donor DNA is refractory to activity stimulation by LEDGF/p75. Yu F; Jones GS; Hung M; Wagner AH; MacArthur HL; Liu X; Leavitt S; McDermott MJ; Tsiang M Biochemistry; 2007 Mar; 46(10):2899-908. PubMed ID: 17298035 [TBL] [Abstract][Full Text] [Related]
18. Discovery of a novel 5-carbonyl-1H-imidazole-4-carboxamide class of inhibitors of the HIV-1 integrase-LEDGF/p75 interaction. Serrao E; Xu ZL; Debnath B; Christ F; Debyser Z; Long YQ; Neamati N Bioorg Med Chem; 2013 Oct; 21(19):5963-72. PubMed ID: 23985689 [TBL] [Abstract][Full Text] [Related]
19. Crystal structures of novel allosteric peptide inhibitors of HIV integrase identify new interactions at the LEDGF binding site. Rhodes DI; Peat TS; Vandegraaff N; Jeevarajah D; Newman J; Martyn J; Coates JA; Ede NJ; Rea P; Deadman JJ Chembiochem; 2011 Oct; 12(15):2311-5. PubMed ID: 21850718 [TBL] [Abstract][Full Text] [Related]
20. Identification of the LEDGF/p75 HIV-1 integrase-interaction domain and NLS reveals NLS-independent chromatin tethering. Vanegas M; Llano M; Delgado S; Thompson D; Peretz M; Poeschla E J Cell Sci; 2005 Apr; 118(Pt 8):1733-43. PubMed ID: 15797927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]